Company / Current Assets per Share
Xeris Biopharma Holdings, Inc. Current Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.61
FY2025
5-year range
$1.15 / $3.34
FY2021-FY2025
Trend
+32.5%
vs FY2024
Sector context
#182 of 210
Health Care
What the data says
Xeris Biopharma Holdings, Inc.'s current assets per share of $1.61 is lower than 87% of companies in the Health Care sector (FY2025). Improved from $1.15 to $1.61 over the past 2 years.
Based on SEC 10-K filings.
1.61 in FY2025 with a 5-year CAGR of -14.7%.
Improved from $1.15 to $1.61 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +2.4%
- 5-Year CAGR
- -14.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 210This company $1.61 Sector average $170.65
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 32.5% year-over-year.
- Ranks #182 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.61 | +32.5% |
| FY2024 | $1.21 | +5.9% |
| FY2023 | $1.15 | -23.4% |
| FY2022 | $1.50 | -55.3% |
| FY2021 | $3.34 | -6.3% |
| FY2020 | $3.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026